报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 94.58% | 1.45% | -0.01% | 4/160 | 22.89% | 迪哲医药 | 97.73% | 行业排名> |
2024-06-30 | 94.59% | 1.63% | 0.02% | 5/160 | 33.26% | 百利天恒 | 97.99% | 行业排名> |
2024-03-31 | 94.57% | 2.44% | 1.19% | 5/160 | 51.37% | 百利天恒 | 98.92% | 行业排名> |
2023-12-31 | 93.45% | 0.69% | 0.24% | 5/160 | 51.37% | 迈威生物 | 98.93% | 行业排名> |
2023-09-30 | 93.23% | 0.34% | 0.16% | 4/160 | 32.75% | 迈威生物 | 99.59% | 行业排名> |
2023-06-30 | 93.08% | 0.84% | 0.83% | 4/160 | 38.61% | 迈威生物 | 99.8% | 行业排名> |
2023-03-31 | 92.31% | -1.01% | -0.53% | 5/160 | 52.91% | 迈威生物 | 99.46% | 行业排名> |
2022-12-31 | 92.81% | 0.07% | -0.11% | 5/160 | 53.57% | 迈威生物 | 99.75% | 行业排名> |
2022-09-30 | 92.91% | 2% | 0.66% | 4/160 | 6.69% | 迈威生物 | 99.67% | 行业排名> |
2022-06-30 | 92.3% | 2% | -1.02% | 4/160 | 21.79% | 迈威生物 | 99.44% | 行业排名> |
2022-03-31 | 93.25% | 2% | 0.54% | 3/160 | 54.47% | 迈威生物 | 98.57% | 行业排名> |
2021-12-31 | 92.75% | 2% | 2% | 7/160 | 55.07% | 首药控股 | 99.93% | 行业排名> |